Return to Advances in Ulcerative Colitis - Volume 4

Advances in Ulcerative Colitis - Volume 4 CME

Copyright © 2008 Medscape.

CME Information

Target Audience

This activity is intended for physicians specializing in the fields of gastroenterology and internal medicine, as well as other healthcare professionals, conducting research and/or providing care for individuals with ulcerative colitis.

Goal

The goal of this activity is to define the latest issues challenging the physician caring for the patient with ulcerative colitis in order to enhance the care of patients with this condition and support quality clinical practice of healthcare professionals involved in their care.

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Discuss the latest data on medical therapies shown to be effective for maintenance of remission in ulcerative colitis, including 5-aminosalicylic acid (5-ASA)-containing medications, azathioprine, and infliximab
  2. Discuss the impact of ulcerative colitis on health-related quality of life, including comparison with the general population and other chronic diseases as well as the effect of therapeutic intervention
  3. Review the latest data regarding the role of surgery in the setting of ulcerative colitis, as reflected in the recent literature

Credits Available

Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

All other healthcare professionals completing continuing education credit for this activity will be issued a certificate of participation.

Physicians should only claim credit commensurate with the extent of their participation in the activity.

Accreditation Statements

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Discuss the latest data on medical therapies shown to be effective for maintenance of remission in ulcerative colitis, including 5-aminosalicylic acid (5-ASA)-containing medications, azathioprine, and infliximab
  2. Discuss the impact of ulcerative colitis on health-related quality of life, including comparison with the general population and other chronic diseases as well as the effect of therapeutic intervention
  3. Review the latest data regarding the role of surgery in the setting of ulcerative colitis, as reflected in the recent literature
Authors and Disclosures

William J. Sandborn, MD
Disclosure: William J. Sandborn, MD, has disclosed that he has received grants for clinical research from, and has served as an advisor or consultant to, Shire Pharmaceuticals and Procter & Gamble Pharmaceuticals. Dr. Sandborn has also disclosed that he has served as a consultant to Salix Pharmaceuticals.


Darrell S. Pardi, MD
Disclosure: Darrell S. Pardi, MD, has disclosed that he has received grants for clinical research from AstraZeneca, Proctor & Gamble, and Salix. Dr. Pardi has also disclosed that he has served as an advisor or consultant to Salix.


David Limsui, MD
Disclosure: David Limsui, MD, has disclosed no relevant financial relationships.


Bret A. Lashner, MD
Disclosure: Bret A. Lashner, MD, has disclosed that he has served as an advisor or consultant to Shire, Elan, Abbott, UCB, Prometheus, and Procter & Gamble.


Maria Gaiso
Disclosure: Maria Gaiso has disclosed no relevant financial relationships.


For Physicians

Medscape

Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.


For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity: CME@medscape.net. For technical assistance, contact CME@webmd.net.

Release Date: March 28, 2008; Valid for credit through March 28, 2009

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. Medscape encourages you to complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

Hardware/Software Requirements

Medscape requires version 4.x browsers or higher from Microsoft or Netscape. Certain educational activities may require additional software to view multimedia, presentation or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Macromedia Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player.


 
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.